고체상 추출법을 기반으로 한 [18F]Fluorocholine 합성법의 최적화 연구
Optimization of Automated Solid Phase Extraction-based Synthesis of [18F]Fluorocholine
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
[18F]Fluorocholine is a radiopharmaceutical used non-invasively in positron emission tomography to diagnose parathyroid adenoma, prostate cancer, and hepatocellular carcinoma by evaluating the choline metabolism. In this study, a radiolabeling method for [18F]fluorocholine was optimized using a solid phase extraction (SPE) cartridge. [18F]Fluorocholine was labeled in two steps using an automated synthesizer. In the first step, dibromomethane was reacted with [18F]KF/K2.2.2/K2CO3 to obtain the intermediate [18F]fluorobromomethane. In the second step, [18F]fluorobromomethane was passed through a Sep-PakⓇ Silica SPE cartridge to remove the impurities and then reacted with N,N-dimethylaminoethanol (DMAE) in a Sep-PakⓇ C18 SPE cartridge to label [18F]fluorocholine. The reaction conditions of [18F]fluorocholine were optimized. The synthesis yield was confirmed according to the number of silica cartridges and DMAE concentration. No statistically significant difference in the synthesis yield of [18F]fluorocholine was observed when using four or three silica cartridges (P＞0.05). The labeling yield was 11.5±0.5% (N=4) when DMAE was used as its original solution. On the other hand, when diluted to 10% with dimethyl sulfoxide, the radiochemical yield increased significantly to 30.1±5.2% (N=20). In conclusion, [18F]Fluorocholine for clinical use can be synthesized stably in high yield by applying an optimized synthesis method.
Abstract
[18F]Fluorocholine is a radiopharmaceutical used non-invasively in positron emission tomography to diagnose parathyroid adenoma, prostate cancer, and hepatocellular carcinoma by evaluating the choline metabolism. In this study, a radiolabeling method for [18F]fluorocholine was optimized using a solid phase extraction (SPE) cartridge. [18F]Fluorocholine was labeled in two steps using an automated synthesizer. In the first step, dibromomethane was reacted with [18F]KF/K2.2.2/K2CO3 to obtain the intermediate [18F]fluorobromomethane. In the second step, [18F]fluorobromomethane was passed through a Sep-PakⓇ Silica SPE cartridge to remove the impurities and then reacted with N,N-dimethylaminoethanol (DMAE) in a Sep-PakⓇ C18 SPE cartridge to label [18F]fluorocholine. The reaction conditions of [18F]fluorocholine were optimized. The synthesis yield was confirmed according to the number of silica cartridges and DMAE concentration. No statistically significant difference in the synthesis yield of [18F]fluorocholine was observed when using four or three silica cartridges (P＞0.05). The labeling yield was 11.5±0.5% (N=4) when DMAE was used as its original solution. On the other hand, when diluted to 10% with dimethyl sulfoxide, the radiochemical yield increased significantly to 30.1±5.2% (N=20). In conclusion, [18F]Fluorocholine for clinical use can be synthesized stably in high yield by applying an optimized synthesis method.
참고문헌 (26)
- Zeisel SH, "Choline and human nutrition", Annu Rev Nutr, 14, pp.269~296 (1994)[DOI]
- 심유진, "콜린의 한국인 영양소 섭취기준 제정 검토를 위한 문헌 고찰 및 향후 과제", Journal of Nutrition and Health, 55(2), pp.211~226 (2022), 한국영양학회[DOI]
- Zeisel SH, "Choline phospholipids : signal transduction and carcinogenesis", FASEB J, 7, pp.551~557 (1993)[DOI]
- Mehedint MG, "Choline’s role in maintaining liver function : new evidence for epigenetic mechanisms", Curr Opin Clin Nutr Metab Care, 16, pp.339~345 (2013)[DOI]
- Michel V, "Choline transport for phospholipid synthesis", Exp Biol Med(Maywood), 231, pp.490~504 (2006)[DOI]
- Blusztajn JK, "Phosphatidylcholine as a precursor of choline for acetylcholine synthesis", J Neural Transm Suppl, 24, pp.247~259 (1987)
- Plathow C, "Tumor cell metabolism imaging", J Nucl Med, 49 Suppl 2, pp.43S~63S (2008)[DOI]
- Tian M, "Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors", Eur J Nucl Med Mol Imaging, 31, pp.1064~1072 (2004)[DOI]
- Hara T, "18F-fluorocholine : a new oncologic PET tracer", J Nucl Med, 42, pp.1815~1817 (2001)
- choline; implications for in vivo imaging with positron emission tomography, "Eur J Nucl Med", 2000, 25~32, https:
- DeGrado TR, "Synthesis and evaluation of(18)F-labeled choline analogs as oncologic PET tracers", J Nucl Med, 42, pp.1805~1814 (2001)
- Schmid DT, "Fluorocholine PET", CT in patients with prostate cancer : initial experience, 2005, pp.235, 623~628
- Talbot JN, "Detection of hepatocellular carcinoma with PET", CT : a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease, 2010, pp.51, 1699~1706
- DeGrado TR, "Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography : initial findings in prostate cancer", Cancer Res, 61, pp.110~117 (2001)
- fluorocholine, "Appl Radiat Isot", 2002, 347~352, https:
- FCH2I) : preparation and reactions with phenol, thiophenol, amide and amine functional groups, "J Fluor Chem", 2004, 1879~1886, https:
- fluoromethyl tosylate, a convenient reagent for radiofluoromethylations, "J Label Compd Radiopharm", 2005, 557~568, https:
- fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer, "Nucl Med Biol", 2008, 255~260, https:
- fluoromethyl tosylate, "Appl Radiat Isot", 2013, 26~32, https:
- FCH via a modified TRACERlab FxFN module, "Appl Radiat Isot", 2017, 190~198, https:
- Kobayashi K, "Image-guided biopsy : what the interventional radiologist needs to know about PET", CT, 2012, pp.32, 1483~1501
- fluoromethylcholine : an important step towards enhanced tumour visualization, "Eur J Nucl Med Mol Imaging", 2010, 2136~2145, https:
- Cornford EM, "Carrier mediated blood-brain barrier transport of choline and certain choline analogs", J Neurochem, 30, pp.299~308 (1978)[DOI]
- Dodia C, "Inhibitors of choline transport in alveolar type II epithelial cells", Am J Respir Cell Mol Biol, 6, pp.426~429 (1992)[DOI]
- Kwee S, "Dimethylaminoethanol reduces 18F-fluoroethylcholine uptake in prostate cancer cells", J Nucl Med, 47(Suppl 1), pp.425~ (2006)[DOI]
- fluorocholine, "Appl Radiat Isot", 2023, 110736~, https: